Imidazoquinoline derivatives

Details for Australian Patent Application No. 2002353241 (hide)

Owner Sanofi-Aventis

Inventors Vargane Szeredi, Judit; Kapui, Zoltan; Balazs, Laszlo; T Nagy, Lajos; Gerber, Katalin; Aranyi, Peter; Urban-Szabo, Katalin; Boer, Kinga; Batori, Sandor; Balogh, Maria; Mikus, Endre; Timari, Geza

Agent Watermark

Pub. Number AU-B-2002353241

PCT Number PCT/HU02/00144

PCT Pub. Number WO2003/053969

Priority P 0105406 21.12.01 HU

Filing date 17 December 2002

Wipo publication date 9 July 2003

Acceptance publication date 10 July 2008

International Classifications

C07D 215/54 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/437 (2006.01)

A61K 31/4545 (2006.01)

A61K 31/4706 (2006.01) - 4-Aminoquinolines

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/06 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/08 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/04 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): P 0105406 21.12.01 HU

2 October 2003 Application Open to Public Inspection

  Published as AU-B-2002353241

13 January 2005 Assignment before Grant

  Sanofi-Synthelabo The application has been assigned to Sanofi-Aventis 2003

10 July 2008 Application Accepted

  Published as AU-B-2002353241

6 November 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002353242-AMLOPIDINE BEZYLATE TABLETS WITH IMPROVED STABILITY

2002353240-Triazolo-quinolin derivatives useful as adenosine receptor ligands